Operating and investment executive focused on growth-stage technology and healthcare opportunities, Robin Gould combines operating leadership with private equity and venture experience across product, commercial strategy and M&A. Known for scaling teams, driving go-to-market expansion and executing strategic exits, she works with boards and management on capital raises, operational transformation and portfolio value creation. Fluent in cross-border transactions and C-suite advisory.
Operating and investment executive focused on growth-stage technology and healthcare opportunities, Robin Gould combines operating leadership with private equity and venture experience across product, commercial strategy and M&A. Known for scaling teams, driving go-to-market expansion and executing strategic exits, she works with boards and management on capital raises, operational transformation and portfolio value creation. Fluent in cross-border transactions and C-suite advisory.
Grows venture and growth-stage tech and healthcare businesses through hands-on operational investing, prioritizing companies with product-market fit and scalable go-to-market motion. Capital allocation favors follow-on support and structured growth rounds tied to performance milestones. Emphasizes operator-led value creation, rigorous commercial KPIs, cross-border M&A optionality and board-level governance to accelerate exits over a medium-term horizon while preserving downside through active portfolio oversight.
Grows venture and growth-stage tech and healthcare businesses through hands-on operational investing, prioritizing companies with product-market fit and scalable go-to-market motion. Capital allocation favors follow-on support and structured growth rounds tied to performance milestones. Emphasizes operator-led value creation, rigorous commercial KPIs, cross-border M&A optionality and board-level governance to accelerate exits over a medium-term horizon while preserving downside through active portfolio oversight.
| Trades 940 | Longs Won 670/940 71% | Profit Factor 28.32 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $588,357.23 |
| Average Win $111,904.48 | Best Trade (Oct 15) $12.85M | Sharpe Ratio -9.54 |
| Average Loss -$9,804.74 | Worst Trade (Oct 14) -$559,010.4 | Z-Score 4.27 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 2w 1d | Expectancy $76,945.45 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 25,641 | 23,077 | 20,513 | 17,949 | 15,385 | 12,821 | 10,256 | 7,692 | 5,128 | 2,564 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 11,810 | $2.35M | $4.04M | - | $1.69M | 71.95% | -0.163% |
ABBV AbbVie Inc. | 2,075 | $359,526.52 | $590,866.62 | - | $231,340.1 | 64.35% | +1.067% |
ABT Abbott Laboratories | 2,647 | $291,985.6 | $277,643.83 | - | -$14,341.77 | -4.91% | +2.492% |
AGG iShares Core U.S. Aggregate Bond ETF | 24,905 | $2.47M | $2.37M | - | -$91,647.11 | -3.72% | +0.559% |
AMAT Applied Materials, Inc. | 683 | $233,528 | $295,544.34 | - | $62,016.34 | 26.56% | -3.116% |
AMD Advanced Micro Devices, Inc. | 1,624 | $232,435 | $917,949.76 | - | $685,514.76 | 294.93% | -0.978% |
AMZN Amazon.com Inc | 4,247 | $702,527.46 | $1.08M | - | $381,179.53 | 54.26% | +0.429% |
ANGL VanEck Fallen Angel High Yield Bond ETF | 19,276 | $554,755.44 | $529,800.86 | - | -$24,954.58 | -4.5% | -0.127% |
BND Vanguard Total Bond Market Index Fund | 15,250 | $1.12M | $1.08M | - | -$44,959.75 | -4% | +0.554% |
BNDX Vanguard Total International Bond ETF | 10,364 | $509,787.58 | $489,025.34 | - | -$20,762.24 | -4.07% | +0.287% |
BRK-B Berkshire Hathaway Inc. | 1,378 | $590,005.34 | $726,908.78 | - | $136,903.44 | 23.2% | +0.22% |
CAT Caterpillar Inc. | 350 | $200,505 | $258,074.24 | - | $57,569.24 | 28.71% | -1.552% |
COST Costco Wholesale Corporation | 489 | $331,186.3 | $479,982.84 | - | $148,796.54 | 44.93% | -0.045% |
EFA iShares MSCI EAFE ETF | 2,050 | $212,967 | $212,339 | - | -$628 | -0.29% | +0.808% |
EFAV iShares MSCI EAFE Min Vol Factor ETF | 2,548 | $199,329.41 | $239,168.02 | - | $39,838.61 | 19.99% | +1.509% |
EWC iShares MSCI Canada ETF | 4,426 | $162,347.77 | $266,577.98 | - | $104,230.21 | 64.2% | +1.637% |
FXH First Trust Health Care AlphaDEX Fund | 2,547 | $263,840.21 | $343,399.27 | - | $79,559.06 | 30.15% | +2.451% |
GLD SPDR Gold Shares | 3,370 | $647,259.32 | $1.28M | - | $636,997.13 | 98.41% | +1.355% |
GME Gamestop Corp. | 33,673 | $637,978.5 | $950,757.15 | - | $312,778.65 | 49.03% | +3.996% |
GOOGL Alphabet Inc | 1,240 | $181,511.71 | $432,426.32 | - | $250,914.61 | 138.24% | +0.314% |